Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rodeghiero

Showing results (131-140 of 266) with videos related to

Pageof 27
Sort By:
Thrombosis and Haemostasis|December 29, 1984
Defective fibrin crosslinking in acute leukemiaF Rodeghiero, T Barbui, A Dal Belin-Peruffo, et al.
Blood|June 15, 1992
Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trialP M Mannucci, P M Tenconi, G Castaman, et al.
Blut|March 1, 1988
Erythema multiforme after intravenous immunoglobulinF Rodeghiero, G Castaman, M Vespignani, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 10, 2000
The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiencyG Castaman, A Tosetto, A Cappellari, et al.
American Journal of Hematology|January 1, 1995
An acquired hemorrhagic disorder of fibrin crosslinking due to IgG antibodies to FXIII, successfully treated with FXIII replacement and cyclophosphamideA Tosetto, F Rodeghiero, E Gatto, et al.
Journal of Thrombosis and Haemostasis : JTH|March 26, 2011
Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluationA Tosetto, G Castaman, I Plug, et al.
British Journal of Haematology|December 31, 1997
Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor VG Castaman, B Lunghi, E Missiaglia, et al.
Thrombosis and Haemostasis|August 1, 1996
Thrombosis in patients with heterozygous and homozygous factor XII deficiency is not explained by the associated presence of factor V LeidenG Castaman, M Ruggeri, A Tosetto, et al.
Blood|June 1, 1990
Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patientsF Rodeghiero, G Avvisati, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
Age-adjusted reference limits for carotid intima-media thickness as better indicator of vascular risk: population-based estimates from the VITA projectA Tosetto, P Prati, C Baracchini, et al.
Pageof 27

Showing results (131-140 of 266) with videos related to

Sort By:
Pageof 27
Thrombosis and Haemostasis|December 29, 1984
Defective fibrin crosslinking in acute leukemiaF Rodeghiero, T Barbui, A Dal Belin-Peruffo, et al.
Blood|June 15, 1992
Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trialP M Mannucci, P M Tenconi, G Castaman, et al.
Blut|March 1, 1988
Erythema multiforme after intravenous immunoglobulinF Rodeghiero, G Castaman, M Vespignani, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 10, 2000
The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiencyG Castaman, A Tosetto, A Cappellari, et al.
American Journal of Hematology|January 1, 1995
An acquired hemorrhagic disorder of fibrin crosslinking due to IgG antibodies to FXIII, successfully treated with FXIII replacement and cyclophosphamideA Tosetto, F Rodeghiero, E Gatto, et al.
Journal of Thrombosis and Haemostasis : JTH|March 26, 2011
Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluationA Tosetto, G Castaman, I Plug, et al.
British Journal of Haematology|December 31, 1997
Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor VG Castaman, B Lunghi, E Missiaglia, et al.
Thrombosis and Haemostasis|August 1, 1996
Thrombosis in patients with heterozygous and homozygous factor XII deficiency is not explained by the associated presence of factor V LeidenG Castaman, M Ruggeri, A Tosetto, et al.
Blood|June 1, 1990
Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patientsF Rodeghiero, G Avvisati, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
Age-adjusted reference limits for carotid intima-media thickness as better indicator of vascular risk: population-based estimates from the VITA projectA Tosetto, P Prati, C Baracchini, et al.
Pageof 27